Publication at First Faculty of Medicine |
2012
Abstract
Immune thrombocytopenia (ITP) is an acquired, immunologically determined disease characterized by temporarily or permanently decreased platelet count and increased risk of bleeding, depending on seriousness of the condition. During recent years, changes in understanding of aetiopathogenetic mechanisms of ITP resulted in significant shifts in terminology, classification and diagnostics of ITP and they also led to introduction of new therapeutic approaches.